Filing Details
- Accession Number:
- 0001144204-13-067674
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-17 16:07:00
- Reporting Period:
- 2013-12-17
- Filing Date:
- 2013-12-17
- Accepted Time:
- 2013-12-17 16:07:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1327467 | Celator Pharmaceuticals Inc | CPXX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566617 | Thomas Scott Jackson | C/O Celator Pharmaceuticals, Inc. 200 Princetonsouth Corp. Center, Ste 180 Ewing NJ 08628 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-12-17 | 3,000 | $3.50 | 3,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
